Clinical Trials Directory

Trials / Completed

CompletedNCT01787227

A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel

A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection

Status
Completed
Phase
—
Study type
Observational
Enrollment
1,500 (actual)
Sponsor
Luminex Molecular Diagnostics · Industry
Sex
All
Age
—
Healthy volunteers
Not accepted

Summary

xTAG RPP assay is a PCR-based assay to detect the presence or absence of viral and bacterial DNA / RNA in clinical specimens (nasopharyngeal swabs). The objective of this study is to establish diagnostic accuracy of the xTAG RPP.

Conditions

Interventions

TypeNameDescription
DEVICExTAG RPP

Timeline

Start date
2015-01-01
Primary completion
2015-09-01
First posted
2013-02-08
Last updated
2016-03-03

Locations

4 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT01787227. Inclusion in this directory is not an endorsement.